CXMT Corporation stock sees CNY 18.0 billion R&D expansion
Published on 10/01/2026 at 12:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSCXMT Corporation (ISIN CNE100007WP2) is directing CNY 18.0 billion toward research and development and backend testing, according to Chosun on September 29, 2026. The investment follows CXMT's move into mass production with its fifth-generation DRAM platform, making capacity execution the central issue for the newly listed memory maker.
Research spending accelerates
The CNY 18.0 billion allocation consists of CNY 13.0 billion for a technology research project and CNY 5.0 billion for a second-phase backend testing base. The projects carry total budgets of CNY 24.1 billion and CNY 10.8 billion, with construction periods of 30 months and 37 months respectively, Global Times reported on September 29, 2026.
The plan also underlines a sharp increase in operating investment. CXMT's research and development spending reached CNY 6.8595 billion in the first half of 2026, up 87.40 percent from the same period a year earlier, while operating cash flow reached CNY 131.1557 billion, about 31 times the prior-year figure, Chosun reported.
Fifth-generation DRAM reaches production
Reuters reported on September 20, 2026, that CXMT's fifth-generation technology platform had entered mass production. The platform uses 11.95-nanometer feature spacing and supports two 24-gigabit LPDDR5X products, each holding 50.00 percent more data than the previous comparable products.
The company also said the platform can produce at least 50.00 percent more gross chip dies per wafer than its fourth-generation platform, using an 8-gigabit baseline. That comparison measures potential dies before defective units are removed, so it describes wafer economics rather than final tested output.
Stock valuation follows execution
CXMT Corporation stock stood at CNY 54.79 on September 30, 2026, versus CNY 55.55 previously. The CNY 0.76 difference represents a 1.37 percent decline against that prior close, placing the market response alongside a capital plan designed to expand both process development and in-house testing.
The company is listed on the Shanghai Stock Exchange under ticker 688825, and its business centers on the design, research and development, manufacturing and sale of dynamic random-access memory products. Its product range covers DDR and low-power DDR chips for mobile devices, personal computers, servers and smart cars.
Execution becomes the next test
The investment gives CXMT more control over two bottlenecks that can limit semiconductor expansion: process development and backend testing. The 30-month research schedule and 37-month testing schedule also mean that the capital commitment is tied to a multiyear rollout rather than an immediate capacity increase.
For investors, the key comparison is between CXMT's technology claims and measurable commercial output. The 50.00 percent wafer-die figure and 87.40 percent first-half research spending increase show the scale of the effort, while future results will determine how efficiently that spending converts into products and revenue.
Shanghai listing and company data
CXMT Corporation stock stood at CNY 54.79 on the Shanghai Stock Exchange on September 30, 2026, while the prior reference value was CNY 55.55. The stock's 1.37 percent decline provides the latest dated market comparison for a company investing CNY 18.0 billion in research and backend testing.
CXMT Corporation stock facts
- Company: CXMT Corporation
- ISIN: CNE100007WP2
- Ticker: 688825
- Primary exchange: Shanghai Stock Exchange
- Primary exchange price: CNY 54.79 as of September 30, 2026
- Sector / Industry: Semiconductors / DRAM memory
